Memorial Sloan-Kettering Cancer Center West Harrison

Harrison, New York 10604

0 studies enrolling now · 7 studies all time

What they study most

Adenocarcinoma of the Prostate, Antimetabolites, Antineoplastic, Castration-resistant Prostate Cancer, Deep Venous Thrombosis, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Gemcitabine, Hormone-resistant Prostate Cancer, Neoplasms, Neoplasms by Site

Studies at this site

• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE — Stopped early
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE — Stopped early
• Cisplatin vs Paclitaxel for Triple Negative Breast Cancer — Completed
• Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer — Completed
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer — Status unconfirmed
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed
• A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations — Stopped early